Abstract
Adenocarcinoma of the seminal vesicle is a rare condition, with fewer than 60 cases described in the literature. Most reports highlight the histopathological characteristics of the tumor; however, the role of chemotherapy, especially in the metastatic setting, is poorly described. In this paper, we describe a patient with metastatic disease, who sustained a response to modified FOLFOX6 as first-line therapy. This platinum-based combination therapy seems effective in this scenario and may provide an opportunity for extended survival and relief of symptoms.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenocarcinoma / drug therapy*
-
Adenocarcinoma / secondary
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Fluorouracil / therapeutic use
-
Genital Neoplasms, Male / drug therapy*
-
Genital Neoplasms, Male / pathology
-
Humans
-
Leucovorin / therapeutic use
-
Male
-
Organoplatinum Compounds / therapeutic use
-
Palliative Care
-
Platinum / administration & dosage
-
Platinum / therapeutic use
-
Seminal Vesicles / pathology*
Substances
-
Organoplatinum Compounds
-
Platinum
-
Leucovorin
-
Fluorouracil